BioNTech (BNTX)
(Delayed Data from NSDQ)
$107.34 USD
-0.16 (-0.15%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $107.40 +0.06 (0.06%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, BioNTech SE Sponsored ADR has a market cap of $25.84B, which represents its share price of $107.50 multiplied by its outstanding shares number of 240.39M. As a large-cap company, BNTX's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BNTX 107.34 -0.16(-0.15%)
Will BNTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BNTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BNTX
MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View
Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect
BNTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings
Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales View
BioNTech SE Sponsored ADR (BNTX) Is Up 4.81% in One Week: What You Should Know
Other News for BNTX
Earnings week ahead: AMD, PLTR, PFE, DIS, O, ET, SHOP, GILD, MCD, CAT, VTRS, BP, UBER, CGC, and more
Bristol-Myers Squibb: Growth Is Taking Its Own Time (Rating Downgrade)
BioNTech Q2 2025 Earnings Preview
Experts helping vaccine advisors are reportedly ousted at CDC
A Look Ahead: BioNTech's Earnings Forecast